These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 15945097)
1. Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance. Fujita T; Washio K; Takabatake D; Takahashi H; Yoshitomi S; Tsukuda K; Ishibe Y; Ogasawara Y; Doihara H; Shimizu N Int J Cancer; 2005 Nov; 117(4):670-82. PubMed ID: 15945097 [TBL] [Abstract][Full Text] [Related]
2. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line. Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876 [TBL] [Abstract][Full Text] [Related]
3. Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein. Xiang QF; Zhang DM; Wang JN; Zhang HW; Zheng ZY; Yu DC; Li YJ; Xu J; Chen YJ; Shang CZ Liver Int; 2015 Mar; 35(3):1010-23. PubMed ID: 24621440 [TBL] [Abstract][Full Text] [Related]
4. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells. Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559 [TBL] [Abstract][Full Text] [Related]
5. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
6. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608 [TBL] [Abstract][Full Text] [Related]
7. COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer. Sui H; Zhou S; Wang Y; Liu X; Zhou L; Yin P; Fan Z; Li Q Carcinogenesis; 2011 May; 32(5):667-75. PubMed ID: 21296766 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation. Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858 [TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135 [TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel. Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145 [TBL] [Abstract][Full Text] [Related]
11. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233 [TBL] [Abstract][Full Text] [Related]
12. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444 [TBL] [Abstract][Full Text] [Related]
13. Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant. Li T; Kong AN; Ma Z; Liu H; Liu P; Xiao Y; Jiang X; Wang L Oncotarget; 2016 Apr; 7(15):20236-48. PubMed ID: 26934120 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines. Wojtowicz K; Januchowski R; Nowicki M; Zabel M Biomed Pharmacother; 2015 Aug; 74():49-56. PubMed ID: 26349962 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the P-glycoprotein relevant for multidrug resistance by intracellular acidification through the crosstalk of MAPK signaling pathways. Jin W; Lu Y; Li Q; Wang J; Zhang H; Chang G; Lin Y; Pang T Int J Biochem Cell Biol; 2014 Sep; 54():111-21. PubMed ID: 25043687 [TBL] [Abstract][Full Text] [Related]
16. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells. Dönmez Y; Gündüz U Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614 [TBL] [Abstract][Full Text] [Related]
17. [Reversal of nomegestrol acetate on multidrug resistance in drug-resistant human breast cancer cell line MCF7/ADR]. Li J; Xu L; He K; Guo W; Zhu X; Zheng Y; Xia P Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):129-32. PubMed ID: 12015032 [TBL] [Abstract][Full Text] [Related]
18. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil. Ye W; Chang HL; Wang LS; Huang YW; Shu S; Dowd MK; Wan PJ; Sugimoto Y; Lin YC Anticancer Res; 2007; 27(1A):107-16. PubMed ID: 17352222 [TBL] [Abstract][Full Text] [Related]
19. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [TBL] [Abstract][Full Text] [Related]
20. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition. Yun UJ; Lee JH; Koo KH; Ye SK; Kim SY; Lee CH; Kim YN Biochem Pharmacol; 2013 May; 85(10):1441-53. PubMed ID: 23473805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]